AIM
ACGN

Advantage Investment Management’s Aceragen Inc ACGN Stock Holding History

Advantage Investment Management’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3
Closed -$1K – 1099
2017
Q3 		$1K Hold
3
– – ﹤0.01% 1010
2017
Q2 		$1K Buy
+3
New +$784 ﹤0.01% 1052
2017
Q1 		– Sell
-69
Closed -$14K – 1053
2016
Q4 		$14K Buy
69
+30
+77% +$7.15K 0.01% 581
2016
Q3 		$13K Hold
39
– – ﹤0.01% 585
2016
Q2 		$8K Hold
39
– – ﹤0.01% 642
2016
Q1 		$10K Buy
39
+18
+86% +$4.81K ﹤0.01% 567
2015
Q4 		$9K Sell
21
-11
-34% -$4.92K ﹤0.01% 594
2015
Q3 		$15K Buy
32
+7
+28% +$3.1K 0.01% 495
2015
Q2 		$13K Buy
25
+16
+178% +$7.34K 0.01% 544
2015
Q1 		$4K Buy
+9
New +$5.49K ﹤0.01% 725

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Advantage Investment Management's ACGN Position: Q4 2017 in Review

Advantage Investment Management sold out of Aceragen Inc (ACGN) in Q4 2017, closing a stake of 3 shares — an estimated $1K sold.

Advantage Investment Management first reported a position in ACGN in Q1 2015 and held it in 10 quarters. The position peaked at $15K in Q3 2015. 106 funds tracked by Wall St. Rank hold ACGN as of Q4 2017.

  • Advantage Investment Management reported no remaining Aceragen Inc position as of Q4 2017 after selling out during the quarter.
  • Advantage Investment Management sold 3 Aceragen Inc shares in Q4 2017, an estimated $1K.
  • Advantage Investment Management first reported a position in Aceragen Inc in Q1 2015 and held it in 10 quarters.
  • Advantage Investment Management's Aceragen Inc position peaked at $15K in Q3 2015.
  • 106 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2017.

Based on Advantage Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.